Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


09.10.2017

3 Anticancer Res
1 Br J Cancer
1 Cancer Res
1 Clin Cancer Res
1 Int J Cancer
2 J Am Acad Dermatol
1 J Clin Oncol
1 Melanoma Res
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. PSINAKIS F, Katseli A, Koutsandrea C, Frangia K, et al
    Uveal Melanoma: GNAQ and GNA11 Mutations in a Greek Population.
    Anticancer Res. 2017;37:5719-5726.
    PubMed     Text format     Abstract available

  2. HU WP, Kuo KK, Senadi GC, Chang LS, et al
    Photodynamic Therapy Using Indolines-Fused-Triazoles Induces Mitochondrial Apoptosis in Human Non-Melanoma BCC Cells.
    Anticancer Res. 2017;37:5499-5505.
    PubMed     Text format     Abstract available

  3. GARMPIS N, Damaskos C, Garmpi A, Dimitroulis D, et al
    Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations?
    Anticancer Res. 2017;37:5355-5362.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. CIRILLO N, Morgan DJ, Pedicillo MC, Celentano A, et al
    Characterisation of the cancer-associated glucocorticoid system: key role of 11beta-hydroxysteroid dehydrogenase type 2.
    Br J Cancer. 2017;117:984-993.
    PubMed     Text format     Abstract available


    Cancer Res

  5. LI J, Yan S, Liu Z, Zhou Y, et al
    Multiregional sequencing reveals genomic alterations and clonal dynamics in primary malignant melanoma of the esophagus.
    Cancer Res. 2017 Sep 29. pii: canres.0938.2017.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  6. KOSTER BD, van den Hout MFCM, Sluijter BJR, Molenkamp BG, et al
    Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials.
    Clin Cancer Res. 2017;23:5679-5686.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. STENEHJEM JS, Veierod MB, Nilsen LT, Ghiasvand R, et al
    Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort.
    Int J Cancer. 2017 Oct 6. doi: 10.1002/ijc.31086.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  8. MARCHETTI MA, Codella NCF, Dusza SW, Gutman DA, et al
    Results of the 2016 International Skin Imaging Collaboration International Symposium on Biomedical Imaging challenge: Comparison of the accuracy of computer algorithms to dermatologists for the diagnosis of melanoma from dermoscopic images.
    J Am Acad Dermatol. 2017 Sep 29. pii: S0190-9622(17)32202.
    PubMed     Text format     Abstract available

  9. HALTEH P, Scher R, Artis A, Lipner SR, et al
    A survey-based study of management of longitudinal melanonychia amongst attending and resident dermatologists.
    J Am Acad Dermatol. 2017;76:994-996.
    PubMed     Text format    


    J Clin Oncol

  10. CHESNEY J, Puzanov I, Collichio F, Singh P, et al
    Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.
    J Clin Oncol. 2017 Oct 5:JCO2017737379. doi: 10.1200/JCO.2017.73.7379.
    PubMed     Text format     Abstract available


    Melanoma Res

  11. ALESSI C, Scapulatempo Neto C, Viana CR, Vazquez VL, et al
    PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival.
    Melanoma Res. 2017 Oct 3. doi: 10.1097/CMR.0000000000000396.
    PubMed     Text format     Abstract available


    PLoS One

  12. HULUR I, Skol AD, Gamazon ER, Cox NJ, et al
    Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma.
    PLoS One. 2017;12:e0185730.
    PubMed     Text format     Abstract available

  13. BRASTER R, Grewal S, Visser R, Einarsdottir HK, et al
    Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
    PLoS One. 2017;12:e0177736.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: